- Home
- LPTH vs ASMB Comparison
LPTH vs ASMB Comparison
Compare LPTH & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- ASMB
- Stock Information
- Founded
- LPTH 1985
- ASMB 2005
- Country
- LPTH United States
- ASMB United States
- Employees
- LPTH N/A
- ASMB N/A
- Industry
- LPTH Semiconductors
- ASMB Biotechnology: Pharmaceutical Preparations
- Sector
- LPTH Technology
- ASMB Health Care
- Exchange
- LPTH Nasdaq
- ASMB Nasdaq
- Market Cap
- LPTH 229.5M
- ASMB 198.6M
- IPO Year
- LPTH 1996
- ASMB 2010
- Fundamental
- Price
- LPTH $6.40
- ASMB $20.65
- Analyst Decision
- LPTH Strong Buy
- ASMB Strong Buy
- Analyst Count
- LPTH 3
- ASMB 4
- Target Price
- LPTH $5.33
- ASMB $41.33
- AVG Volume (30 Days)
- LPTH 1.6M
- ASMB 144.2K
- Earning Date
- LPTH 11-06-2025
- ASMB 11-06-2025
- Dividend Yield
- LPTH N/A
- ASMB N/A
- EPS Growth
- LPTH N/A
- ASMB N/A
- EPS
- LPTH N/A
- ASMB N/A
- Revenue
- LPTH $33,626,969.00
- ASMB $33,247,000.00
- Revenue This Year
- LPTH $19.59
- ASMB $11.57
- Revenue Next Year
- LPTH $47.43
- ASMB N/A
- P/E Ratio
- LPTH N/A
- ASMB N/A
- Revenue Growth
- LPTH 2.59
- ASMB 54.77
- 52 Week Low
- LPTH $1.11
- ASMB $7.75
- 52 Week High
- LPTH $6.97
- ASMB $27.17
- Technical
- Relative Strength Index (RSI)
- LPTH 58.73
- ASMB 34.14
- Support Level
- LPTH $5.17
- ASMB $22.36
- Resistance Level
- LPTH $5.59
- ASMB $22.93
- Average True Range (ATR)
- LPTH 0.41
- ASMB 1.22
- MACD
- LPTH -0.27
- ASMB -0.64
- Stochastic Oscillator
- LPTH 93.90
- ASMB 4.77
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.